CD4 and neoplasm: Particularly, CD4+ tumor-infiltrating cells displayed an HLA-DR MHC class II phenotype and interacted with “ionized calcium-binding adaptor molecule 1” (IBA1)-positive antigen-presenting cells (APCs).